摘要
2021年1月,Cardiology Journal发布了《高尿酸血症合并心血管高风险患者诊断和治疗的专家共识:2021年更新版》(简称2021年更新版共识),其是对《2018年高尿酸血症合并心血管高风险患者诊断和治疗共识》的更新。由来自波兰、意大利的多位心血管方面的专家共同制订,旨在对高尿酸血症合并心血管高风险患者的疾病管理进行指导。2021年更新版共识的核心内容包括:“高尿酸血症最新的流行病学特点、高尿酸血症在心血管疾病中的病理生理学效应、遗传因素对个体化诊断和治疗策略的影响、高尿酸血症和心血管疾病相关的最新研究、评估当前血尿酸阈值预测心血管事件风险、高尿酸血症的治疗选择对于心血管的影响、治疗和管理策略、对临床医生最相关的指导信息”等内容。本文针对2021年更新版共识更新要点做详细解读,以期给中国临床医生对高尿酸血症合并心血管高风险患者的诊断和治疗提供了更多参考内容。
In January 2021,the Cardiology Journal published Expert Consensus for the Diagnosis and Treatment of Patient with Hyperuricemia and High Cardiovascular Risk:2021 Update(short for the latest consensus in 2021),which is an update of the 2018 Expert Consensus for the Diagnosis and Treatment of Patient with Hyperuricemia and High Cardiovascular Risk.It was jointly developed by many cardiovascular experts from Poland and Italy to guide the disease management of people with hyperuricemia and high cardiovascular risk.The core content of the latest consensus in 2021 includes:"the latest epidemiological characteristics of hyperuricemia,the pathophysiological effects of hyperuricemia in cardiovascular diseases,the influence of genetic factors on individualized diagnosis and treatment strategies,and the latest research related to cardiovascular disease,assessment of the current uric acid threshold to predict the risk of cardiovascular events,the cardiovascular impact of hyperuricemia treatment options,treatment and management strategies,and the most relevant guidance information for clinicians."This article provides a detailed interpretation of the latest consensus in 2021,in order to provide more reference for Chinese clinicians in the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk.
作者
冯高科
徐林
FENG Gaoke;XU Lin(Department of Cardiology,Renmin Hospital of Wuhan University/Cardiovascular Research Institute,Wuhan University/Hubei Key Laboratory of Cardiology,Wuhan 430060,China)
出处
《实用心脑肺血管病杂志》
2021年第5期1-7,共7页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
高尿酸血症
心血管高风险
诊断
治疗
共识
Hyperuricemia
High cardiovascular risk
Diagnosis
Treatment
Consensus
